Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE−/− mice
2019 · Biomedicine & Pharmacotherapy · 66 citations
https://doi.org/10.1016/j.biopha.2019.109410
Y
Yanming Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
291
Papers
4.8K
Citations
33
h-index
106
i10-index
Yanming Chen is an academic researcher from Ningbo University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Retinal Diseases and Treatments & Diabetes Management and Research. The author has an h-index of 33, co-authored 248 publications.
ORCID: 0000-0001-6856-9058Papers by this author
worksHuman Gingiva-Derived Mesenchymal Stem Cells Ameliorate Streptozoticin-induced T1DM in mice via Suppression of T effector cells and Up-regulating Treg Subsets
2017 · Scientific Reports · 63 citations
https://doi.org/10.1038/s41598-017-14979-5
A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling
2020 · Signal Transduction and Targeted Therapy · 35 citations
https://doi.org/10.1038/s41392-020-0142-x
Induced regulatory T cells suppress Tc1 cells through TGF-β signaling to ameliorate STZ-induced type 1 diabetes mellitus
2021 · Cellular and Molecular Immunology · 35 citations
https://doi.org/10.1038/s41423-020-00623-2
Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling
2024 · Acta Pharmaceutica Sinica B · 29 citations
https://doi.org/10.1016/j.apsb.2024.03.011
Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis
2022 · Crystal Growth & Design · 28 citations
https://doi.org/10.1021/acs.cgd.2c00370
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat